3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Intraductal, Noninfiltrating
1
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
1
Interventions
Tamoxifen
5
Specimen Handling
4
exemestane
2
Letrozole
2
Anastrozole
2
fezolinetant
1
elacestrant
1
Testosterone
1
Surgical Procedures, Operative
1
Omacor
1
Neoadjuvant Therapy
1
FAPI-46
1
Biopsy
1
4-hydroxy-N-desmethyltamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
fezolinetant
×
30 days
×
Clear all
NCT06617455
2026-05-06
VEnT
University of Michigan Rogel Cancer Center
Phase 2
Terminated
9 enrolled